Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Excellent. Welcome to the BofA London Healthcare Conference. So my name is Geoff Meacham I'm a senior biopharma analyst here at BofA. And we're thrilled to have Amgen with us and up here on stage is Peter Griffith, CFO; and Arvind Sood, Senior Director of Investor Relations. So guys, welcome to the conference. Looking forward to the discussion.
Geoff, thank you. Thanks for inviting us. We're glad to be here. Thank you, Bank of America. And I'd just like to open up with a few thoughts.
Yes, let's do that.
First maybe share with the group. Recall our focus on long-term growth and our sharing with the group back in February about our guidance through 2030, mid-single-digit growth, upper single-digit,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
